Kingstone Capital Partners Texas, LLC Emergent Bio Solutions Inc. Call Options Transaction History
Kingstone Capital Partners Texas, LLC
- $624 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding EBS
# of Institutions
179Shares Held
38MCall Options Held
128KPut Options Held
153K-
Black Rock Inc. New York, NY3.84MShares$28 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$23.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.5MShares$18.2 Million0.01% of portfolio
-
American Century Companies Inc Kansas City, MO2.3MShares$16.7 Million0.01% of portfolio
-
State Street Corp Boston, MA1.71MShares$12.5 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $363M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...